| Literature DB >> 36132103 |
Xiaoya Yu1,2,3,4, Xiao Liu1,2,3,4, Wanchuan Ding1,2,3,4, Jun Wang1,2,3,4, Gang Ruan1,2,3,4.
Abstract
Recently, supraparticle protein-nanoparticle co-assemblies (or 'supraparticle co-assemblies' for short) have attracted considerable interest due to their fundamental and technological value. However, it remains challenging to form supraparticle co-assemblies with high stability. Here, we show that using hydrophobic interaction, instead of the previously used electrostatic and van der Waals interactions, as the primary driving force can lead to instant formation of exceptionally stable supraparticle co-assemblies with minimal external energy input. Our formation method of supraparticle co-assemblies simply involves mixing globular proteins (e.g., bovine serum albumin) with hydrophobic nanoparticles (e.g., hydrophobic magnetic nanoparticles and hydrophobic quantum dots) without significant energy input (e.g., sonication or stirring). Upon mixing of hydrophobic nanoparticles and proteins, the formation of supraparticle co-assemblies only takes <1 minute. Further incubation of the mixture for several hours results in a gradual increase of the size uniformity of supraparticle co-assemblies. The formed supraparticle co-assemblies have been colloidally stable for 6 months and counting, and can withstand harsh environments such as basic and acidic pH, high temperature, high dilution, and serum. Co-encapsulation of different sizes/types of nanoparticles is found to be feasible and the co-encapsulation number ratio of different nanoparticles is well-controlled by the feeding ratio. Proof-of-concept studies show the potential of the supraparticle co-assemblies for biological imaging, delivery, and modulation. The combination of very rapid formation, minimal energy consumption, highly stable products, and inexpensive raw materials of this hydrophobic interaction-driven process meets many of the main goals of 'ideal' nano-manufacturing. Thus, this process could serve as the foundation of ideal manufacturing of supraparticle co-assemblies. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 36132103 PMCID: PMC9417729 DOI: 10.1039/c9na00328b
Source DB: PubMed Journal: Nanoscale Adv ISSN: 2516-0230
Fig. 1Characterization of supraparticle co-assemblies. (a) TEM image of SPIONs@BSA. (b) DLS results of SPIONs@BSA. (c) Control of the particle size of supraparticle co-assemblies by varying the nanoparticle concentration. The TEM images of the assembly samples with the smallest and the largest DLS sizes are also shown as insets. (d) Enhanced fluorescence intensity of a QDs@BSA supraparticle assembly compared with that of a single QD. (e) TGA results of SPIONs@BSA.
Fig. 2Colloidal stability of supraparticle co-assemblies. (a) Hydrodynamic diameter and fluorescence intensity of supraparticle co-assemblies at 4 °C in PBS (pH 7.4). (b) Hydrodynamic diameter of SPIONs@BSA in acidic environments at 4 °C. (c) Hydrodynamic diameter of SPIONs@BSA in basic environments at 4 °C. (d) Hydrodynamic diameter changes of SPIONs@BSA in response to dilution. Along the x-coordinate the dilution ratio increases from the left to the right. The concentration corresponding to dilution ratio 1 is 200 μg mL−1. (e) Hydrodynamic diameter of SPIONs@BSA in bovine serum at 37 °C.
Fig. 3Studies of the formation process of supraparticle co-assemblies. (a) Use of the potential exchange of QDs with different fluorescent colors to examine the formation process of supraparticle co-assemblies. The results indicate that supraparticle co-assemblies form virtually instantly (<1 min; shown as ‘0 h’ in the figure legend). The results also indicate that once the supraparticle co-assemblies are formed, there is no exchange of nanoparticles between different assemblies. Scale bar 5 μm. (b) Use of DLS to examine the formation process of supraparticle co-assemblies. The results indicate that supraparticle co-assemblies form instantly (<1 min; shown as ‘0 h’ in the figure legend). The results also indicate that once the supraparticle co-assemblies are formed, their hydrodynamic diameter does not change significantly (i.e., there is no size growth). The results also indicate that after the supraparticle co-assemblies are formed, there is a gradual decrease in size polydispersity (i.e., there is size focusing).
Fig. 4Co-encapsulation of nanoparticles of different types/sizes into supraparticle co-assemblies. (a) Different types of nanoparticles (SPIONs and QDs here) can be co-encapsulated to achieve multifunctionality (superparamagnetism and fluorescence here). (b) The number ratio of different colors (sizes) of QDs co-encapsulated into a supraparticle co-assembly can be controlled by the feed ratio of the assembly ‘reaction’. gQD: green QD; rQD: red QD.
Fig. 5Schematic of the formation process of supraparticle co-assemblies.
Fig. 6Proof-of-concept studies of biological applications of supraparticle co-assemblies. (a and b) QDs@BSA were conjugated with the RGD peptide, and the formed QDs@BSA-RGD were able to specifically label and image U87MG cells. (a) Shows representative images. (b) Shows quantification results using the images obtained from the experiments of (a). Images of ∼100 cells from each sample were used for the quantification. ***P < 0.001. (c–e) The bi-functionality of SPIONs&QDs@BSA-RGD could be used to achieve combined magnetic targeting and fluorescence imaging of biological cells. (c) Shows the experimental setup. U87MG cells were cultured on the bottom of the dish. SPIONs&QDsBSA-RGD dispersed in the cell culture medium were incubated with the cells. (d) Shows representative images. (e) Shows quantification results using the images obtained from the experiments of (d). Images of ∼100 cells from each sample were used for the quantification. ***P < 0.001. (f) An anticancer drug doxorubicin (DOX) was loaded onto supraparticle co-assemblies to achieve cancer cell-killing effects. The DOX-loaded supraparticle co-assemblies were freshly prepared for the cancer cell-killing experiments (storage time < 1 day). (g) Cell viability studies show that supraparticle co-assemblies are biocompatible.